Clinical Trials
at the Comprehensive Cancer Center Freiburg – CCCFOne of the main research foci at the Comprehensive Cancer Center Freiburg – CCCF is translational research. This provides an additional therapy option with promising new substances that have not yet been approved, particularly for patients who do not respond to the standard therapy.
The CCCF tests these new substances with different methods. Human trials are preceded by extensive testing in the laboratory and on animals. New therapeutic approaches are tested in phases I to III of the clinical trials. In addition to efficacy, the safety of patients is always a primary concern. Participants in clinical trials are observed closely by physicians from different disciplines.
A positive vote from the responsible ethics commission is the prerequisite for every clinical trial. The ethics commission is composed of physicians, ethicists, theologians, jurists, and often also patient representatives.
Click here for more information from German Cancer Aid on the procedure for conducting clinical trials (in German).
We cooperate closely with the Center for Clinical Trials (ZKS), which was founded at the University Medical Center in 1997.
The results of clinical trials conducted at the Comprehensive Cancer Center Freiburg – CCCF benefit all cancer patients. Each treatment is documented and made available to other oncology centers. The doctors monitor the course of the illness or recovery in long-term observations.
Clinical Trials Currently Recruiting
You can find information about the current clinical trials at the Freiburg Cancer Center – CCCF in the following brochures (in German).
QuickQueck – the Clinical Trial Search Tool
The QuickQueck (in German) clinical trial search tool allows you to filter and view trials based on three criteria: entity, line of therapie, and age. It is also possible to display the entire list of trials.
Search Trials
in the • German Clinical Trials Register (in German)
• NCT, clinical.trials.gov
- In the Department of Internal Medicine I, Hematology, Oncology, and Stem Cell Transplantation (in German)
- In the Department of Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases
- Department of Gynecology and Obstetrics (in German)
- At the Center for Pediatrics and Adolescent Medicine (in German)
- Department of Neurosurgery
- Department of Plastic Surgery
- In the Department of Urology (in German)
- In the Department of Dermatology and Venereology (in German)
- Department of Radiation Oncology (in German)
- Department of Thoracic Surgery
- In the Center for Chronic Immunodeficiency (CCI)(in German)
- Risk Perception and Treatment Adherence in Cancer Patients during COVID-19 Pandemic: A Multi-national Study (Chair of Self-help Research)
Digital Decision-Making Tool for Participating in Clinical Trials for Cancer (in German)
Dear patients, dear those affected, and dear relatives,
Is there an opportunity for you to participate in a clinical trial? Would you like to learn more about clinical trials for yourself or your loved ones? Are you unsure whether participating in a trial is the right choice for you?
You are not alone in making this decision! We have developed a digital decision-making tool to guide you through the topic of clinical trials for cancer, help you prepare for your next doctor’s visit, and make the decision-making process easier.
Click here for the decision-making tool (in German): freiburg.share-to-care.de
Clinical Trials Center and Early Clinical Trial Unit (ECTU)
Central unit for Phase I, I/II, and complex Phase II trials
learn more (in German)
Contact
Clinical Trials Coordination Office and Early Clinical Trial Unit (ECTU)
University Medical Center Freiburg
Comprehensive Cancer Center Freiburg – CCCF
Hugstetter Straße 53
D-79106 Freiburg
cccf.ectu@uniklinik-freiburg.de